Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02999451
Other study ID # 123
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2017
Est. completion date December 31, 2019

Study information

Verified date June 2020
Source First Affiliated Hospital, Sun Yat-Sen University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

POEM is a new intervention for the treatment of achalasia and has been reported to relieve the dysphagia symptom effectively. Although the cost of POEM method is less than the method of Laparoscopic Heller Myotomy and Fundoplication, it is still of an economic burden for the patients with achalasia. In this trial, investigators plan to use snare to assist POEM procedure, to observe the safety, efficacy and cost-effectiveness of this method, compared with other knifes-assisted procedure.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria:

- Age between 18-70 years

- Diagnosed as achalasia base on high resolution manometry, barium esophagram and Upper endoscopy

- Signed written informed consent

Exclusion Criteria:

- ASA class > ?

- Previous endoscopic or surgical treatment for achalasia

- Esophageal malignancy

- Pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Device:
snare-assisted POEM
POEM is performed by using a snare which is retracted into the sheath to expose the tip, leaving a 1-2mm length for operation. After submucosal injection, an initial 2-cm mucosal incision is made by a snare in the posterior esophageal wall. A submucosal tunnel from the esophagus to the gastric cardia is created using a snare. Full-thickness myotomy is performed and extended 2-3 cm beyond the esophagogastric junction (EGJ) using a snare. The mucosal incision is closed with endoclips.
knife-assisted POEM
POEM is performed by using a conventional endoscopic knife. After submucosal injection, an initial 2-cm mucosal incision is made by a knife in the posterior esophageal wall. A submucosal tunnel from the esophagus to the gastric cardia is created using a knife. Full-thickness myotomy is performed and extended 2-3 cm beyond the esophagogastric junction (EGJ) using a knife. The mucosal incision is closed with endoclips.

Locations

Country Name City State
China First Affiliated Hospital of Sun Yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
First Affiliated Hospital, Sun Yat-Sen University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Clinical success rates Clinical success is defined as a post-POEM Eckardt score =3 without additional treatment (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011). 12 months after treatment
Secondary Procedure-related adverse events Adverse events are defined and graded according to the American Society for Gastrointestinal Endoscopy lexicon (Cotton PB et al, Gastrointest Endosc 2010). Incidental findings of pneumoperitoneum, pneumothorax, pneumomediastinum, pleural effusion on postoperative imaging, and subcutaneous emphysema were documented while not considered as adverse events. baseline to 12 months after treatment
Secondary Procedure time Procedure time is measured from the start of submucosal injection until mucosal entry closure. POEM procedure
Secondary The volume of intraoperative bleeding POEM procedure
Secondary The use of hemostatic forceps POEM procedure
Secondary Postoperative pain requiring the use of tramadol Pain related to POEM procedure requiring the use of tramadol pain medication. Through hospital stay after procedure, an average of 2-7 days
Secondary The length of postoperative hospital stay Through hospital stay after procedure, an average of 2-7 daysc
Secondary Total hospital costs of treatment per participants Through hospital stay after procedure, an average of 2-7 days
Secondary Eckardt score The Eckardt score assesses the severity of achalasia symptoms by combining the sum of symptom frequency scores for dysphagia, regurgitation, and chest pain and a weight loss score. Each component can be graded from 0 to 3 points. The total range is 0 to 12, with higher scores indicating more severe symptoms (Eckardt AJ et al, Nat Rev Gastroenterol Hepatol 2011). baseline, 3 months and 12 months after treatment
Secondary Manometry parameters Manometry parameters include lower esophageal sphincter (LES) pressure and integrated relaxation pressure (IRP) on high resolution manometry. baseline and 3 months after treatment
Secondary Maximum esophageal diameter on barium esophagram baseline and 3 months after treatment
Secondary Gastroesophageal reflux disease questionnaire (GerdQ) score The GerdQ has been developed as a tool to facilitate the symptom-based diagnosis of GERD. Scores ranging from 0 to 3 were applied for the four positive predictors (heartburn, regurgitation, sleep disturbance due to reflux symptoms and use of over-the-counter medications for reflux symptoms) and from 3 to 0 for two negative predictors (epigastric pain and nausea). The GerdQ score was calculated as the sum of these scores, giving a total score ranging from 0 to 18. A total GerdQ score >7 is considered indicative of significant GERD symptoms (Jones R et al, Aliment Pharmacol Ther 2009). baseline, 3 months and 12 months after treatment
Secondary Reflux esophagitis on post-POEM endoscopy The severity of reflux esophagitis is graded according to the Los Angeles classification (Armstrong D et al, Gastroenterology 1996). 3 months after treatment
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03962179 - Feasibility and Efficacy of a Combination of a SEMS and Vacuum Wound Treatment (VACStent) N/A
Withdrawn NCT02663206 - Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection in Spastic Esophageal Disorders N/A
Active, not recruiting NCT00188344 - A Randomized Comparison of Laparoscopic Myotomy and Pneumatic Dilatation for Achalasia N/A
Recruiting NCT04578769 - Assessment of Different Modified POEM for Achalasia N/A
Not yet recruiting NCT05010889 - Quality of Life After POEM for Achalasia
Recruiting NCT02572193 - To Assess the Feasibility of Same Day Discharge Following a POEM Procedure N/A
Terminated NCT02606578 - Achalasia Patient Reported Outcomes
Active, not recruiting NCT01750385 - Bacteremia and Procalcitonin Levels in Peroral Endoscopic Myotomy for Achalasia N/A
Active, not recruiting NCT03404739 - Single- Versus Multiple-dose Antimicrobial Prophylaxis for The Prevention of Infectious Complications Associated With Peroral Endoscopic Myotomy(POEM) for Achalasia Phase 2/Phase 3
Completed NCT04112693 - Assessment of the Neuro-glio-epithelial Unit (NGEU) in Biopsies Taken During Peroral Endoscopic Myotomy (POEM) for Achalasia: a Feasibility and Safety Study. N/A
Recruiting NCT05602272 - Respiratory and Hemodynamic Implications of Endoscopic Myotomy of the Esophagus and Stomach
Recruiting NCT05113173 - Study on the Relationship Between Pathological Features of Achalasia and Prognosis of Per-oral Endoscopic Myotomy
Completed NCT00490750 - Laparoscopic Dor Versus Toupet Fundoplication for the Treatment of Idiopathic Esophageal Achalasia N/A
Recruiting NCT02518542 - Per Oral Endoscopic Myotomy (POEM) and Prolonged Dilatation (PRD) for Achalasia N/A
Recruiting NCT00260585 - Esophageal Cancer Risk Registry
Recruiting NCT05899842 - Routine Versus Symptomatic Protein Pump Inhibitor Therapy for Prevention of Gastroesophageal Reflux After Per Oral Endoscopic Myotomy for Esophageal Achalasia N/A
Completed NCT03702647 - Ropivacaine For Post-POEM Pain Control N/A
Recruiting NCT01637311 - Peroral Endoscopic Remyotomy for Failed Heller Myotomy N/A
Completed NCT00004416 - Randomized Study of Botulinum Toxin Type A for Achalasia N/A
Not yet recruiting NCT06027190 - Randomized Controlled Study of Optical 3D Navigated Repetitive Transcranial Magnetic Stimulation for Achalasia. N/A